Severe Crohn's Disease - A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by an investigational drug in Patients with Moderate to Severe Crohn’s Disease - CURRENTLY RECRUITING

Adult VTE - A Phase 3 Randomized, Double-blind, Parallel-group, Multi-center Study of the Safety and Efficacy of XXX  for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization - CURRENTLY RECRUITING

HAE Quality of Life Survey - Canadian Participants Only - CURRENTLY RECRUITING

Ulcerative Colitis - A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by an investigational drug in Patients with Moderate to Severe Ulcerative Colitis - CURRENTLY RECRUITING

H1N1 Flu - A Phase 4, Randomized, Double-Blinded Controlled Trial Comparing High vs Standard Dose Oseltamivir in Severe, Influenza Infection in ICU (H1N1) - NOT RECRUITING

Dry Eye - A Multi-Center, Parallel-Group, Double-Masked, Randomized, Placebo-Controlled Study of the Effects of XXX Ophthalmic Solution, 2% in Subjects with Dry Eye Disease and a Central Corneal Staining Score of 3 (NEI Scale)- COMPLETED

Adult Heart Failure - A Phase 3 Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of XXX  in Subjects With Decompensated Heart Failure  - COMPLETED

Pediatric Meningitis Vaccine - A Phase 3, Randomized, Observer-blind, Multi-Center Study to Compare the Safety and Immunogenicity of One Dose of Novartis XXX Vaccine with One Dose of Licensed Meningococcal ACWY Conjugate Vaccine (Menactra.) Administered to Healthy Children 2-5 Years of Age - COMPLETED

Major Depressive Disorder - A Phase 2a 6-Week Randomized, Double-Blind, Placebo-Controlled Study of XXX 80 mg q.d. and 80 mg t.i.d. in the Treatment of Adults with Major Depressive Disorder and Concomitant Anxiety - COMPLETED

Baby Conjuctivitis - Phase 4 - A 7-Day, Randomized, Double-Masked, Parallel Group, Multicenter Study To Evaluate the Safety and Efficacy of Topical XXX  0.3% Ophthalmic Solution Compared with Topical XXX  0.5% Ophthalmic Solution for the Treatment of Presumed Bacterial Conjunctivitis in Subjects from Birth to 31 Days of Age  – COMPLETED

Peadiatric Hepatitis Vaccine - A double-blind, randomized, multicenter study of the safety, tolerability, and immunogenicity of licenced vaccine and modified process vaccine in healthy hepatitis B vaccine-naïve infants. – COMPLETED

IVIG - A pilot study of Quality of Life, Mood, Sleepiness, and Fatigue in Patients with Primary Immune Deficiency Receiving Intravenous Immunoglobulin (IVIG) – COMPLETED

Pneumonia - A Phase III Double-Blinded, Randomized, Parallel Group, Multi-Center, Multi-National Comparative Study of the Safety and Efficacy of XXX 300 mg QD to XXX 250 mg BID for the Treatment of Community-Acquired Pneumonia in Adults – COMPLETED

Pediatric Epilepsy - A 19-week, randomized, double-blind, multicenter, placebo-controlled safety study to evaluate the cognitive and neuropsychological effects of XXX  20 - 60 mg/kg/day, divided in twice daily dosing, as adjunctive treatment in children 4 - 16 years old, inclusive, with partial onset seizures – COMPLETED 

Pediatric Epilepsy - A Multi-Center, Open-Label, Long-Term, Follow-Up Study Of The Safety And Efficacy Of XXX In Children With Partial Onset Seizures – COMPLETED